These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9375978)

  • 1. Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cells.
    Le Brigand L; Virsolvy A; Peyrollier K; Manechez D; Godfroid JJ; Guardiola-Lemaître B; Bataille D
    Br J Pharmacol; 1997 Oct; 122(4):786-91. PubMed ID: 9375978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro mechanism of action on insulin release of S-22068, a new putative antidiabetic compound.
    Le Brigand L; Virsolvy A; Manechez D; Godfroid JJ; Guardiola-Lemaître B; Gribble FM; Ashcroft FM; Bataille D
    Br J Pharmacol; 1999 Nov; 128(5):1021-6. PubMed ID: 10556939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell toxicity of ATP-sensitive K+ channel-blocking insulin secretagogues.
    Rustenbeck I; Krautheim A; Jörns A; Steinfelder HJ
    Biochem Pharmacol; 2004 May; 67(9):1733-41. PubMed ID: 15081872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
    Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
    J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The putative imidazoline receptor agonist, harmane, promotes intracellular calcium mobilisation in pancreatic beta-cells.
    Squires PE; Hills CE; Rogers GJ; Garland P; Farley SR; Morgan NG
    Eur J Pharmacol; 2004 Oct; 501(1-3):31-9. PubMed ID: 15464060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose concentration-dependent potentiation of insulin secretion by a new chemical entity, KCP256.
    Mori K; Takasaki K; Katoh Y; Yano H; Ueno K; Ichimura M; Kusaka H; Nomoto Y; Higo K; Nakanishi S
    Eur J Pharmacol; 2005 Dec; 528(1-3):176-82. PubMed ID: 16316644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets.
    Chan SL; Pallett AL; Morgan NG
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
    Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
    Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3T3-L1 adipocytes reduces Kir6.2 channel expression in MIN6 insulin-secreting cells in vitro].
    Zhao YF; Zhu YL; Chen C
    Sheng Li Xue Bao; 2004 Apr; 56(2):253-7. PubMed ID: 15127139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repaglinide upon nutrient metabolism, biosynthetic activity, cationic fluxes and insulin release in rat pancreatic islets.
    Louchami K; Jijakli H; Sener A; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):155-68. PubMed ID: 9583090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery.
    Zaitsev SV; Efanov AM; Efanova IB; Larsson O; Ostenson CG; Gold G; Berggren PO; Efendić S
    Diabetes; 1996 Nov; 45(11):1610-8. PubMed ID: 8866568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazoline binding sites in the endocrine pancreas: can they fulfil their potential as targets for the development of new insulin secretagogues?
    Morgan NG; Chan SL
    Curr Pharm Des; 2001 Sep; 7(14):1413-31. PubMed ID: 11472276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines .
    Rondu F; Le Bihan G; Wang X; Lamouri A; Touboul E; Dive G; Bellahsene T; Pfeiffer B; Renard P; Guardiola-Lemaitre B; Manechez D; Penicaud L; Ktorza A; Godfroid JJ
    J Med Chem; 1997 Nov; 40(23):3793-803. PubMed ID: 9371245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
    Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
    Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat.
    Berdeu D; Gross R; Puech R; Loubatières-Mariani MM; Bertrand G
    Eur J Pharmacol; 1995 Feb; 275(1):91-8. PubMed ID: 7774667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
    Bleck C; Wienbergen A; Rustenbeck I
    Diabetologia; 2005 Dec; 48(12):2567-75. PubMed ID: 16283242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between imidazoline compounds and sulphonylureas in the regulation of insulin secretion.
    Mourtada M; Brown CA; Smith SA; Piercy V; Chan SL; Morgan NG
    Br J Pharmacol; 1997 Jun; 121(4):799-805. PubMed ID: 9208151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different modes of action of the imidazoline compound RX871024 in pancreatic beta-cells. Blocking of K+ channels, mobilization of Ca2+ from endoplasmic reticulum, and interaction with exocytotic machinery.
    Zaitsev SV; Efanov AM; Raap A; Efanova IB; Schloos J; Steckel-Hamann B; Larsson O; Ostenson CG; Berggren PO; Mest HJ; Efendic S
    Ann N Y Acad Sci; 1999 Jun; 881():241-52. PubMed ID: 10415922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonidine-displacing substance and its putative role in control of insulin secretion: a minireview.
    Chan SL
    Gen Pharmacol; 1998 Oct; 31(4):525-9. PubMed ID: 9792210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.